Gsk (GSK) Current Taxes (2016 - 2025)
Historic Current Taxes for Gsk (GSK) over the last 17 years, with Q3 2025 value amounting to -$437.1 million.
- Gsk's Current Taxes rose 4077.37% to -$437.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$437.1 million, marking a year-over-year increase of 4077.37%. This contributed to the annual value of -$898.6 million for FY2024, which is 24449.44% down from last year.
- Latest data reveals that Gsk reported Current Taxes of -$437.1 million as of Q3 2025, which was up 4077.37% from -$775.1 million recorded in Q2 2025.
- In the past 5 years, Gsk's Current Taxes ranged from a high of $659.2 million in Q4 2021 and a low of -$988.4 million during Q3 2021
- Over the past 5 years, Gsk's median Current Taxes value was -$574.5 million (recorded in 2021), while the average stood at -$448.8 million.
- In the last 5 years, Gsk's Current Taxes soared by 8461.9% in 2022 and then crashed by 24539.75% in 2024.
- Gsk's Current Taxes (Quarter) stood at $659.2 million in 2021, then dropped by 16.19% to $552.4 million in 2022, then grew by 12.33% to $620.6 million in 2023, then crashed by 245.4% to -$902.3 million in 2024, then skyrocketed by 51.56% to -$437.1 million in 2025.
- Its Current Taxes was -$437.1 million in Q3 2025, compared to -$775.1 million in Q2 2025 and -$791.0 million in Q1 2025.